Simplex Trading’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-4,565
| Closed | -$216K | – | 8395 |
|
|
2025
Q3 | $216K | Buy |
+4,565
| New | +$221K | ﹤0.01% | 4854 |
|
|
2025
Q2 | – | Sell |
-40,853
| Closed | -$1.86M | – | 8523 |
|
|
2025
Q1 | $1.65M | Buy |
40,853
+17,998
| +79% | +$763K | ﹤0.01% | 2221 |
|
|
2024
Q4 | $635K | Buy |
+22,855
| New | +$692K | ﹤0.01% | 3296 |
|
|
2024
Q2 | – | Sell |
-10,088
| Closed | -$216K | – | 8673 |
|
|
2024
Q1 | $254K | Buy |
+10,088
| New | +$242K | ﹤0.01% | 4590 |
|
|
2023
Q4 | – | Sell |
-33,582
| Closed | -$662K | – | 8687 |
|
|
2023
Q3 | $1.7M | Sell |
33,582
-21,419
| -39% | -$997K | ﹤0.01% | 2220 |
|
|
2023
Q2 | $2.57M | Buy |
55,001
+47,387
| +622% | +$2.17M | ﹤0.01% | 1768 |
|
|
2023
Q1 | $291K | Sell |
7,614
-18,672
| -71% | -$832K | ﹤0.01% | 3869 |
|
|
2022
Q4 | $1.44M | Sell |
26,286
-52,085
| -66% | -$2.23M | ﹤0.01% | 2131 |
|
|
2022
Q3 | $2.67M | Buy |
78,371
+78,268
| +75,988% | +$1.2M | ﹤0.01% | 1715 |
|
|
2022
Q2 | $0 | Sell |
103
-68
| -40% | -$709 | ﹤0.01% | 9843 |
|
|
2022
Q1 | $2K | Buy |
+171
| New | +$2.99K | ﹤0.01% | 9808 |
|
|
2021
Q4 | – | Sell |
-11,642
| Closed | -$258K | – | 10374 |
|
|
2021
Q3 | $295K | Sell |
11,642
-500
| -4% | -$11.3K | ﹤0.01% | 4926 |
|
|
2021
Q2 | $301K | Sell |
12,142
-55,921
| -82% | -$1.57M | ﹤0.01% | 4979 |
|
|
2021
Q1 | $1.97M | Buy |
+68,063
| New | +$2.06M | ﹤0.01% | 1617 |
|
|
2020
Q3 | – | Sell |
-20
| Closed | – | – | 7703 |
|
|
2020
Q2 | $0 | Buy |
+20
| New | +$457 | ﹤0.01% | 7516 |
|
Other funds holding AKRO
Simplex Trading's AKRO Position: Q4 2025 in Review
Simplex Trading sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 4,565 shares — an estimated $216K sold.
Simplex Trading first reported a position in AKRO in Q2 2020 and held it in 15 quarters. The position peaked at $2.67M in Q3 2022. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.
- Simplex Trading reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 4,565 Akero Therapeutics shares in Q4 2025, an estimated $216K.
- Simplex Trading first reported a position in Akero Therapeutics in Q2 2020 and held it in 15 quarters.
- Simplex Trading's Akero Therapeutics position peaked at $2.67M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.